Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Francesca Maria Sambataro"'
Autor:
Sebastiano Emanuele Torrisi, Nicolas Kahn, Julia Wälscher, Markus Polke, Joyce S. Lee, Philip L. Molyneaux, Francesca Maria Sambataro, Claus Peter Heussel, Carlo Vancheri, Michael Kreuter
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: Almost one-third of fibrosing ILD (fILDs) have a clinical disease behavior similar to IPF, demonstrating a progressive phenotype (PF-ILD). However, there are no globally accepted criteria on the definition of a progressive phenotype in no
Externí odkaz:
https://doaj.org/article/6d71226f6567447d97e4cff192dd83f6
Autor:
Sebastiano Emanuele Torrisi, Nicolas Kahn, Julia Wälscher, Nilab Sarmand, Markus Polke, Kehler Lars, Monika Eichinger, Claus Peter Heussel, Stefano Palmucci, Francesca Maria Sambataro, Gianluca Sambataro, Domenico Sambataro, Carlo Vancheri, Michael Kreuter
Publikováno v:
BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Fibrosing, non-idiopathic pulmonary fibrosis (non-IPF) interstitial lung diseases (fILDs) are a heterogeneous group of diseases characterized by a different amount of inflammation and fibrosis. Therapy is currently based on cortic
Externí odkaz:
https://doaj.org/article/31ba4f3e3ed3410c893583025e50db57
Autor:
Nicolas Kahn, Gianluca Sambataro, Claus P. Heussel, Carlo Vancheri, Michael Kreuter, Sebastiano Emanuele Torrisi, Francesca Maria Sambataro
Publikováno v:
Idiopathic interstitial pneumonias.
Background: Fibrosing interstitial lung diseases other than IPF can develop a progressive phenotype (PF-ILD). While recent clinical trials have gained significant insights into management aspects for PF-ILD, different definitions were applied. We the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e1e4c50b3553bdb3ecfadd89f541e3e
https://doi.org/10.1183/13993003.congress-2020.3713
https://doi.org/10.1183/13993003.congress-2020.3713